Back to Search

PHAT

Phathom Pharmaceuticals, Inc. Common Stock
Data: 2026-08-21
$8.87
Price
3.14%
Change
$18.31
52W High
$8.21
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Quick Stats
Aug 21, 2026

65.2

AI Score

HOLD

0.63

Volume Ratio

TBA

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

PHAT Stock Summary

Last updated Aug 21, 2026

PHAT is currently trading at $8.87, positioned below its 200-day moving average of $12.32, suggesting bearish momentum. The stock has a 52-week range of $8.21 to $18.31.

Technical Analysis: The 50-day moving average stands at $10.35, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.128, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.307, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PHAT at 65.2/100 with a HOLD recommendation.

PHAT (Phathom Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 41.128
CMF (20) -0.307
ROC (10) 3.743
ADX (14) 25.313
Indicator Value
MACD (12,26,9) -0.443
AROONOSC (14) 64.286
WILLAMS %R (14) -57.003
MFI (14) 61.695
PHAT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PHAT Price vs Max Options Open Interest
PHAT Max Change In Options Open Interest

PHAT Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PHAT Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PHAT Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PHAT Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Phathom Pharmaceuticals, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

PHAT Moving Averages Analysis

PHAT (Phathom Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 9.03
20 9.3
30 9.92
50 10.35
100 10.98
200 12.32

PHAT Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 695.7 million
Earnings/Share ($) -1.15
Net Profit Margin (%) -0.4134
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.0298
EPS Estimate Next Year ($) 1.1098
WallStreet Target Price ($) 21.50
Most Recent Quarter